Cerence Earnings Calls
| Release date | Nov 19, 2025 |
| EPS estimate | -$0.660 |
| EPS actual | - |
| Revenue estimate | 55.299M |
| Revenue actual | - |
| Expected change | +/- 20.37% |
| Release date | Aug 06, 2025 |
| EPS estimate | -$0.340 |
| EPS actual | $0.0900 |
| EPS Surprise | 126.47% |
| Revenue estimate | 55.299M |
| Revenue actual | 62.236M |
| Revenue Surprise | 12.55% |
| Release date | May 07, 2025 |
| EPS estimate | $0.340 |
| EPS actual | $0.530 |
| EPS Surprise | 55.88% |
| Revenue estimate | 75.341M |
| Revenue actual | 78.01M |
| Revenue Surprise | 3.54% |
| Release date | Feb 06, 2025 |
| EPS estimate | -$0.270 |
| EPS actual | -$0.0300 |
| EPS Surprise | 88.89% |
| Revenue estimate | 49.076M |
| Revenue actual | 50.896M |
| Revenue Surprise | 3.71% |
Last 4 Quarters for Cerence
Below you can see how CRNC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 06, 2025 |
| Price on release | $12.74 |
| EPS estimate | -$0.270 |
| EPS actual | -$0.0300 |
| EPS surprise | 88.89% |
| Date | Price |
|---|---|
| Jan 31, 2025 | $12.46 |
| Feb 03, 2025 | $11.37 |
| Feb 04, 2025 | $12.07 |
| Feb 05, 2025 | $13.10 |
| Feb 06, 2025 | $12.74 |
| Feb 07, 2025 | $14.48 |
| Feb 10, 2025 | $16.50 |
| Feb 11, 2025 | $14.65 |
| Feb 12, 2025 | $14.28 |
| 4 days before | 2.25% |
| 4 days after | 12.09% |
| On release day | 13.03% |
| Change in period | 14.61% |
| Release date | May 07, 2025 |
| Price on release | $10.00 |
| EPS estimate | $0.340 |
| EPS actual | $0.530 |
| EPS surprise | 55.88% |
| Date | Price |
|---|---|
| May 01, 2025 | $9.22 |
| May 02, 2025 | $9.65 |
| May 05, 2025 | $10.06 |
| May 06, 2025 | $9.94 |
| May 07, 2025 | $10.00 |
| May 08, 2025 | $8.78 |
| May 09, 2025 | $9.29 |
| May 12, 2025 | $9.91 |
| May 13, 2025 | $10.17 |
| 4 days before | 8.46% |
| 4 days after | 1.70% |
| On release day | -12.20% |
| Change in period | 10.30% |
| Release date | Aug 06, 2025 |
| Price on release | $8.58 |
| EPS estimate | -$0.340 |
| EPS actual | $0.0900 |
| EPS surprise | 126.47% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $8.60 |
| Aug 01, 2025 | $8.14 |
| Aug 04, 2025 | $8.56 |
| Aug 05, 2025 | $8.55 |
| Aug 06, 2025 | $8.58 |
| Aug 07, 2025 | $9.12 |
| Aug 08, 2025 | $9.16 |
| Aug 11, 2025 | $9.31 |
| Aug 12, 2025 | $10.89 |
| 4 days before | -0.233% |
| 4 days after | 26.92% |
| On release day | 6.29% |
| Change in period | 26.63% |
| Release date | Nov 19, 2025 |
| Price on release | - |
| EPS estimate | -$0.660 |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $9.42 |
| Nov 12, 2025 | $9.11 |
| Nov 13, 2025 | $8.54 |
| Nov 14, 2025 | $8.36 |
| Nov 17, 2025 | $7.87 |
Cerence Earnings Call Transcript Summary of Q2 2025
Cerence reported a strong Q2 2025: revenue of $78.0M (above guidance), adjusted EBITDA of $29.5M, gross margin of 77%, and $13.1M of free cash flow — the fourth consecutive quarter of positive FCF. The company raised full-year profitability and cash flow expectations while reiterating FY revenue guidance of $236M–$247M. Management highlighted product and go-to-market progress: market launch and early customer deals for Cerence XUI (hybrid agentic AI), demonstrated multimodal edge capabilities (with NVIDIA and MediaTek), and new non-automotive initiatives (VoiceTopping with Code Factory). Key commercial wins and programs entered production this quarter, including Mercedes‑Benz MBUX (4th gen), Kawasaki 2‑wheeler, and GenAI rollouts with Hyundai, Kia, and PSA. Operational improvements from last year’s restructuring drove a 32% decline in non‑GAAP operating expenses and contributed to margin expansion. PPU (price-per-unit) trended up (TTM $4.87 vs $4.51 prior year) driven by higher connected-vehicle attachment (29% vs 26% a year ago). Cerence flagged limited tariff impact so far but noted early customer pricing pressure and timeline shifts; the tariff situation remains fluid. Financial position: $122.8M cash & marketable securities; management plans to use cash to repay $60.1M of convertible notes due in June and expects to maintain >$70M cash afterward. Backlog remains ~ $960M (5‑year). Risks include macro/auto production volatility and ongoing IP litigation (cases vs Samsung; new action vs Microsoft/Nuance). Management expects Q3 revenue of $52M–$56M, adjusted EBITDA $1M–$4M, and FY adjusted EBITDA and free cash flow now expected to be $28M–$34M and $25M–$35M, respectively.
Sign In
Buy CRNC